| Literature DB >> 29234385 |
Anfeng Xiang1, Ke Cheng1, Xueyong Shen1, Ping Xu1, Sheng Liu1.
Abstract
Although acupuncture is gaining popularity for the treatment of nonspecific pain, the immediate analgesic effect of acupuncture has never been reviewed. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) on disease-related pain to critically evaluate the immediate effect of acupuncture for pain relief. The PubMed and Cochrane Central Register of Controlled Trials databases as well as three Chinese databases including the China National Knowledge Infrastructure (CNKI), Wanfang, and VIP platforms were searched through November 2016. The outcome was the extent of pain relief from baseline within 30 min of the first acupuncture treatment. We evaluated all RCTs comparing acupuncture with other interventions for disease-related pain. Real acupuncture showed statistically significantly greater pain relief effect compared to sham acupuncture (SMD, -0.56; 95% confidence interval [CI], -1.00 to -0.12; 9 RCTs) and analgesic injection (SMD, -1.33; 95% CI, -1.94 to -0.72; 3 RCTs). No serious adverse events were documented. Acupuncture was associated with a greater immediate pain relief effect compared to sham acupuncture and analgesic injections. Further RCTs with stricter design and methodologies are warranted to evaluate the immediate pain relief effect of acupuncture for more disease-related pain.Entities:
Year: 2017 PMID: 29234385 PMCID: PMC5676441 DOI: 10.1155/2017/3837194
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Flow diagram showing the number of studies included and excluded from the systematic review.
Characteristics of randomized controlled trials.
| Study, year | Country | Disease |
| Mean age | Acupuncture | Control | Time point after | Pain |
|---|---|---|---|---|---|---|---|---|
| Chen and Li [ | China | Renal colic | 51 (39/12) | 39.72 (12.23) | EA (KI5, GB25, BL63, RN3, tender points; 30 minutes) | Intramuscular Fortanodyn injection | 10 min | VAS |
|
| ||||||||
| Inoue et al. [ | Japan | Low back pain | 31 (21/10) | 69.03 (7.06) | MA (one most painful point; 20 seconds) | Nonpenetrating SA | Immediately | VAS |
|
| ||||||||
| Inoue et al. [ | Japan | Low back pain | 26 (14/12) | 72.20 (7.62) | MA ( two to five tender points; 20 seconds) | Local dibucaine injection | Immediately | VAS |
|
| ||||||||
| Liu et al. [ | China | Dysmenorrhea | 501 (0/501) | 22.40 (2.80) | EA (SP6; 30 minutes) | (1) EA at unrelated point | immediately | VAS |
|
| ||||||||
| Lu et al. [ | China | Knee OA | 20 (unclear) | 63.85 (5.95) | EA (GB34, SP9, SP10, ST34, ST36; 30 minutes) | Sham EA at SPs | Immediately | VAS |
|
| ||||||||
| Mejuto Vázquez et al. [ | Spain | Neck pain | 17 (8/9) | 24.53 (5.54) | DN (MTrPs; 25–30 seconds) | No treatment | 10 min | NRS |
|
| ||||||||
| Maeda et al. [ | USA | CTS | 59 (10/49) | 49.1 (9.8) | EA (PC7, TW5 or SP6, LI4; more than 5 minutes) | Nonpenetrating SA | Immediately | VAS |
|
| ||||||||
| Nabeta and Kawakita [ | Japan | Neck and shoulder pain | 34 (10/24) | 32.5 (11.37) | MA (two to twelve tender points; 5 minutes) | Nonpenetrating SA | Immediately | VAS |
|
| ||||||||
| Shin et al. [ | Korea | Low back pain | 58 (34/24) | 38.31 (7.97) | Motion style acupuncture (DU16, LR2, LI11; 30 minutes) | Local diclofenac sodium injection | 30 min | NRS |
|
| ||||||||
| Stival et al. [ | Brazil | Fibromyalgia | 36 (5/31) | 50.83 (9.51) | MA (PC6, HT7, SP6, LI4, LR2, ST36; 20 minutes) | Penetrating at SPs | Immediately | VAS |
|
| ||||||||
| Su et al. [ | China | Low back pain | 60 (35/25) | 39.6 (12.71) | MA (two ankle points; 30 minutes) | Nonpenetrating SA | Immediately | VAS |
|
| ||||||||
| Yang et al. [ | China | Sore throat | 74 (37/37) | 28.87 (13.78) | MA (LI4; removing the needle after eliciting the sensation) | Penetrating at SP | 1 min | VAS |
|
| ||||||||
| Zhang et al. [ | China | Migraine | 110 (52/58) | 24.50 (3.03) | EA (GB20, SJ5, GB8, GB34; 30 minutes) | Penetrating at SPs | Immediately | NRS |
Notes. Mean (standard deviation); CTS: carpal tunnel syndrome; DN: dry needling; EA: electroacupuncture; F: female; M: male; MA: manual acupuncture; N: number; SA: sham acupuncture; SP: sham acupoint.
Risk of bias summary.
| Study, year | Sequence | Allocation concealment | Participants and assessor blinding | Treatment provider blinding | Incomplete outcome data addressed | Free of selective reporting | others |
|---|---|---|---|---|---|---|---|
| Chen and Li [ | Low | Unclear[b] | High[c] | High | Low | Low | Low |
| Inoue et al. [ | Low | Low | Low | High | Low | Low | Low |
| Inoue et al. [ | Low | Unclear[b] | High[c] | High | Low | Low | Low |
| Liu et al. [ | Low | Low | Low | High | Low | Low | Low |
| Lu et al. [ | Unclear[a] | Unclear[b] | Low | High | Low | Low | Low |
| Mejuto-Vázquez et al. [ | Low | Low | High[d] | High | Low | Low | Low |
| Maeda et al. [ | Unclear[a] | Unclear[b] | Unclear[e] | High | Low | Low | High[f] |
| Nabeta and Kawakita [ | Low | Unclear[b] | Low | High | Low | Low | Low |
| Shin et al. [ | Low | Low | High[c] | High | Low | Low | Low |
| Stival et al. [ | Low | Unclear[b] | Low | High | Low | Low | Low |
| Su et al. [ | Low | Low | Low | High | Low | Low | Low |
| Yang et al. [ | Low | Low | Low | High | Low | Low | Low |
| Zhang et al. [ | Low | Low | Low | High | Low | Low | Low |
[a]Lu et al. 2010 and Maeda et al. 2013 RCT claimed to have randomly assigned participants but did not describe the methods in detail; [b]Chen and Li 2012, Inoue et al. 2009, Maeda et al. 2013, Lu et al. 2010, Nabeta and Kawakita 2002, and Stival et al. 2014 did not mention allocation concealment; [c]Chen and Li 2012, Inoue et al. 2009, and Shin et al. 2013 compared acupuncture versus analgesia injection, and the participants, who were also the outcome assessors, could not be blinded; [d] Mejuto-Vázquez et al. 2014 compared acupuncture versus no treatment, and the participants, who were also the outcome assessors, could not be blinded; [e]Maeda et al. 2013 RCT used nonpenetrating sham acupuncture as control but did not evaluate the credibility of the sham; [f]for Maeda et al. 2013 RCT, the baseline was not comparable in the two groups.
Figure 2Acupuncture versus sham acupuncture: pain. 95% CI, confidence interval; Std., standardized.
Figure 3Acupuncture versus analgesic injection: pain. 95% CI, confidence interval; Std., standardized.
Figure 4Subgroup analysis with the duration of pain (acute versus chronic) for sham-controlled trials. 95% CI, confidence interval; Std., standardized.
Sensitivity analysis of included studies.
| Study, year | Statistics with study removed | |||||
|---|---|---|---|---|---|---|
| Difference in means | Lower limit | Upper limit |
|
|
| |
|
| ||||||
| Inoue et al. 2006 | −0.5 | −0.97 | −0.04 | 2.13 | 0.03 | 86% |
| Maeda et al. 2013 | −0.58 | −1.08 | −0.09 | 2.31 | 0.02 | 87% |
| Nabeta and Kawakita 2002 | −0.61 | −1.10 | −0.13 | 2.48 | 0.01 | 87% |
| Su et al. 2010 | −0.47 | −0.93 | −0.02 | 2.06 | 0.04 | 84% |
| Liu et al. 2014 | −0.62 | −1.20 | −0.04 | 2.10 | 0.04 | 87% |
| Lu et al. 2010 | −0.51 | −0.97 | −0.05 | 2.17 | 0.03 | 87% |
| Stival et al. 2014 | −0.51 | −0.98 | −0.04 | 2.14 | 0.03 | 86% |
| Yang et al. 2012 | −0.50 | −0.97 | −0.03 | 2.09 | 0.04 | 85% |
| Zhang et al. 2015 | −0.72 | −1.06 | −0.38 | 4.17 | <0.0001 | 68% |
|
| ||||||
| Chen and Li 2012 | −1.56 | −2.30 | −0.82 | 4.14 | <0.0001 | 51% |
| Inoue et al. 2009 | −1.41 | −2.33 | −0.49 | 3.00 | 0.003 | 79% |
| Shin et al. 2013 | −1.00 | −1.48 | −0.53 | 4.12 | <0.0001 | 0% |
Figure 5Subgroup analysis with the type of sham (nonpenetrating versus penetrating) for sham-controlled trials (excluding study by Zhang et al. [42]). 95% CI, confidence interval; Std., standardized.
Figure 6Subgroup analysis with the duration of pain (acute versus chronic) for sham-controlled trials (excluding study by Zhang et al. [42]). 95% CI, confidence interval; Std., standardized.